ALTAMIRA THERAPEUTICS LTD (CYTO) Stock Cash Flow
NASDAQ:CYTO - Nasdaq - BMG0360L1349 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -2.79M | -3.87M | -26.53M | -17.06M | -8.20M | |||
| Depreciation Amortization | 114.75K | 119.30K | 120.00K | 80.00K | 20.00K | |||
| Change In Working Capital | 5.70M | 1.62M | 4.49M | 180.00K | 300.00K | |||
| Interest Paid | 130.48K | 148.34K | 20.00K | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 20.00K | |||
| Other non cash items | -567.72K | -117.63K | 13.23M | 3.13M | 3.04M | |||
| OPERATING CASH FLOW | 4.61M | -614.08K | -8.68M | -13.67M | -4.84M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -2.14M | -3.33M | -2.32M | |||
| Other Investing Activity | 2.82K | 2.46K | 0.00 | -180.00K | 0.00 | |||
| INVESTING CASH FLOW | 2.82K | 2.46K | -2.14M | -3.51M | -2.31M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.59M | 1.05M | 5.92M | -70.00K | 1.52M | |||
| Stock Issued/Repurchased | 7.13M | 10.51M | 3.96M | 6.84M | 16.08M | |||
| Other Financing Activity | 1.32M | 1.19M | -60.00K | -160.00K | -640.00K | |||
| FINANCING CASH FLOW | -4.71M | 1.19M | 9.83M | 6.61M | 16.96M | |||
| Exchange Rate Effect | -36.95K | -595.00 | 20.00K | 290.00K | 70.00K | |||
| CHANGE IN CASH | -129.44K | 577.56K | -970.00K | -10.28M | 9.88M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 4.61M | -614.08K | -8.68M | -13.67M | -4.84M | |||
| Capital Expenditure | N/A | 0.00 | -2.14M | -3.33M | -2.32M | |||
| FREE CASH FLOW | 4.61M | -614.08K | -10.82M | -17.00M | -7.16M | |||
All data in USD